Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Double-blind Comparative Trial-

NCT01397448 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT01397448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01397448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Double-blind Comparative Trial-
Lead sponsor
Eisai Co., Ltd.
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2011
Completion date
June 30, 2013
Enrollment
472 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

gastric or duodenal ulcers caused by low-dose aspirin